OraSure Technologies (OSUR) vs Pro-Dex (PDEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pro-Dex (PDEX) has outperformed OraSure Technologies (OSUR) over the past year, gaining 91.3% versus a gain of 18.0%. Over five years, PDEX leads with a +144.3% price change compared with -64.5% for OSUR. OraSure Technologies is the larger company by market cap ($261.7 million vs $201.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OSUR | PDEX |
|---|---|---|
| Share price | $3.80 | $62.21 |
| Market cap | $261.74M | $201.14M |
| 1-day change | +1.74% | -0.94% |
| YTD return | +54.13% | +63.20% |
| 1-year return | +18.04% | +91.35% |
| 5-year return | -64.51% | +144.26% |
| P/E ratio (TTM) | — | 15.10 |
| Forward P/E | — | 18.51 |
| EPS (TTM) | $-0.69 | $4.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.58 | $77.00 |
| 52-week low | $2.08 | $23.47 |
| Distance from 52-week high | -17.14% | -19.21% |
| Analyst consensus | none | none |
| Avg. price target upside | +5.40% | +18.95% |
| Average volume | 480.26K | 81.57K |
| Shares outstanding | 68.97M | 3.23M |
| Employees | 500 | 201 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed OSUR by 73.3 percentage points over the past year.
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Health Care · Medical/Dental Instruments · 500 employees
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
OSUR vs PDEX FAQ
Which is bigger, OraSure Technologies or Pro-Dex?
OraSure Technologies (OSUR) is larger, with a market capitalization of $261.74M compared with $201.14M for Pro-Dex (PDEX).
Which stock has performed better over the past year, OSUR or PDEX?
PDEX returned +91.35% over the past 12 months, compared with +18.04% for OSUR (price return, excluding dividends). Past performance does not predict future results.
Are OraSure Technologies and Pro-Dex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.